TABLE 4.
Authors | Study design | Phenotype | MLS | Markers | Genetic position* |
---|---|---|---|---|---|
Studies in type 1 diabetes | |||||
Moczulski et al. (8) (Caucasians) | DSP (n = 66) | Proteinuria and ESRD | 3.1 | D3S1308 | 157.0 |
Osterholm et al. (20) (Caucasians) | DSP (n = 83) | Proteinuria | 2.7 | D3S3606–D3S3694 | 134.6–148.8 |
Current study (Caucasians) | DSP (n = 50) DSP (n = 50) | Proteinuria ESRD | 1.5 1.1 | rs1002200 rs1381768 | 95.6 154.2 |
Studies in type 2 diabetes | |||||
Imperatore et al. (24) (Pima Indians) | ASP (n = 90) | Proteinuria and ESRD | 1.5 | D3S3053 | 174 |
Bowden et al. (25) (African Americans) | ASP (n = 206) | ESRD | 1.3 (4.6)† | D3S2460 | 126 |
Krolewski et al. (21) Caucasians) | Quantitative trait loci using 5,656 relative pairs | UAE | 1.0 | D3S1744 | 153.4 |
Placha et al. (22) (Caucasians) | Quantitative trait loci using 5,187 relative pairs | GFR estimated by cystatin C (nondiabetic relative pairs only) | 2.8 | D3S1744 | 153.4 |
Chen et al. (26) (West Africans) | Quantitative trait loci using 360 relative pairs | Serum creatinine | 2.2 | D3S2418 | 210 |
cM according to the deCODE map.
Ordered subset analysis.